Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Covance is dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
Type 1 Diabetes: Technology & Tools For Conducting Clinical Research, June 7, 11:00 a.m. EDT
This T1DM webinar will be hosted by Dr. Barry Goldstein (Covance) with panelists Dr. Sanjoy Dutta (JDRF) and Dr. Manasi Jaiman (Covance). They will explore the current state of technologies and tools that can enhance clinical research, and the trial landscape/challenges faced by clinical development programs in T1DM.
How do you ensure quality in global clinical trials?
Read our white paper for challenges and considerations in running a global trial.
Learn how to efficiently analyze and manage your pharmacokinetic (PK) data
Gain insights in our latest blog.
Bioanalysis Education Center: Covance leads the way in bioanalytical capabilities and solutions, igniting innovation with exceptional science and timely answers.
Access the latest scientific posters, list of non-proprietary/generic assays, publications and info sheets.
Rare Disease and Orphan Drugs: accelerate complex studies globally
A range of individual approaches can be integrated to accelerate your progress of complex rare disease studies across the world. Learn how to address key development challenges.
GSK and Covance Xcellerate® partner to leverage informatics technology in worldwide portfolio
Xcellerate® Informatics sets a new standard for monitoring of clinical trials. Read the blog.
Request a Partnering Meeting at BIO International 2018
Whether you’re looking for the right investment or licensing partner for your molecule or preparing to take your asset through to commercialization, let’s connect at BIO International 2018, June 4-8.
Multiple indications. A fundamental approach.
Experience with 14 of the 15 top IMID drugs. Over 470 IMID clinical trials in the past five years. A broad, well-coordinated platform of services
Introducing biosimilar CMC analytical master files
Innovative & invaluable solutions for biosimilar development. Pre-developed, risk-mitigated biosimilarity assessment, testing solutions, data evaluation and consultation.
Do you have the right precision medicine partner to optimize your program development?
The right partner can help you navigate the companion diagnostics journey from bench to bedside, starting with which pathway - IVD, LDT or both - is right for you.
Central Laboratory Services (ELMS)
Is your team more focused on managing referral labs than actual science?
As clinical trials become more complex, they require more specialty testing. There's a way to support this requirement without wasting valuable in-house resources on lab management.
End-to-end drug & diagnostic development support for a new immuno-oncology agent
Find out how Covance/LabCorp helped a prominent pharmaceutical company enable a faster, more effective launch of their immuno-oncology drug.
Proactive risk management for ICH E6 compliance
Understand the recent changes to the ICH E6 guideline. Leverage a three-tier strategy.
Have you visited the NASH Education Center?
We’re pleased to announce the launch of the NASH Education Center. Access the latest thoughts from experts through webinars, case studies, blogs, info sheets and scientific articles.
Immuno-oncology education center
Learn about the latest advances in immuno-oncology. Download webinars, white papers, case studies and blogs.
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.